News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
mRNA pioneer Moderna wants to grow and thrive past its initial COVID-19 vaccine success. “To continue to build the best version of Moderna, we have established seven priorities for 2023,” says CEO Stephane Bancel: as the company outlines goals that range...
Sandoz intends to launch Hyrimoz citrate-free HCF in the US on July 1, 2023.
A US FDA panel of advisors concluded that there was a lack of substantial evidence to indicate that Biogen’s investigational drug, tofersen, was effective in treating a rare and aggressive form of ALS. But the experts voted unanimously that the...
The UK BioIndustry Association has welcomed a new enhanced R&D tax relief rate, announced in the government’s Spring Budget last week.